ASP Newsletter: Summer 2021, Volume 57, Issue 2
While much work has been devoted to investigating potential inhibitors of protein tyrosine kinases (PTKs) and the downstream effects on chronic diseases such as cancer, little has been reported for the protein tyrosine phosphatase, the enzyme responsible for the regeneration of the PTK. Is the phosphatase an additional potential target for drug lead development?
At some point in graduate school, most people experience imposter syndrome. Imposter syndrome is when you doubt your skills and talents, minimize your own accomplishments, and have an internalized fear of being exposed as a “fraud.”
This summer, the ASP will host a virtual symposium series July 16, 23, and 30 entitled “Vanguards of Natural Product Research 2021.” These events will highlight the work and creativity of students and postdocs in the natural products community (aspmeetings. pharmacognosy.us/), and the abstract deadline is June 1.
NEWSLETTER STAFF
Edward J. Kennelly, PhD
Editor In Chief
Patricia Carver, MA
Copyediting & Proofreading
Nancy Novick
Design & Production
Gordon Cragg, PhD
Mario Figueroa, PhD
Joshua Kellogg, PhD
Michael Mullowney, PhD
Guido Pauli, PhD
Patricia Van Skaik, MA, MLS
Jaclyn Winter, PhD
ASP Newsletter Committee
Contribution deadlines
Spring: Feb. 15; Summer: May 15 Fall: Aug. 15; Winter:Nov. 15
Please send information to
Edward J. Kennelly, PhD Editor In Chief,
ASP Newsletter
Department of Biological Sciences
Lehman College, CUNY
250 Bedford Park Blvd. West Bronx, NY 10468
718-960-1105
asp.newsletter@
lehman.cuny.edu
ISSN 2377-8520 (print) ISSN 2377-8547 (online)